GENETICALLY MODIFIED SENDAI VIRUS FOR TREATMENT OF TUMOURS

摘要

The present invention relates to a genetically modified paramyxovirus, to a pharmaceutical composition comprising this paramyxovirus, to the use of a genetically modified paramyxovirus for therapeutic and/or prophylactic treatment of a tumour, and to a process for producing a pharmaceutical composition for therapeutic and/or prophylactic treatment of a tumour.